Remove 2008 Remove Doctors Remove Trials
article thumbnail

Discovering an Antimalarial Drug in Mao’s China

Codon

After four years of a national effort to “ scientize Chinese medicine ” ( zhongyi kexuehua ), which designated Chinese doctors to study Western biomedicine, Mao Zedong reversed course in 1954, setting a new priority of “ Western doctors study Chinese medicine ( xiyi xuexi zhongyi ).” Nobody had an answer.

Drugs 130
article thumbnail

New Sandoz Board of Directors appointed

The Pharma Data

Before joining Nestlé he served as CFO at Takeda Pharmaceuticals, one of the largest publicly listed companies in Japan, between 2013 and 2015, and CFO at Millicom, a NASDAQ listed global mobile phone operator based in Luxembourg, between 2008 and 2013. Urs Riedener, was CEO of Swiss consumer goods company EMMI Group between 2008 and 2022.

Science 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Running Through Life with Type 1 Diabetes

Conversations in Drug Development Trends

Despite another kidney infection in the first year, I graduated early in December 2008. In 2011, I participated in a Type 1 diabetes clinical trial and have continued exploring study opportunities ever since. In 2011, I participated in a Type 1 diabetes clinical trial and have continued exploring study opportunities ever since.

article thumbnail

Women in Stem with Vicky Marsh Durban

Drug Target Review

As an undergraduate and as a doctoral candidate, I studied intestinal biology in a lab that used mostly animal models, because they were the only appropriate models that were available at the time. Organoids are being used in more and more clinical trials.

Doctors 59
article thumbnail

A Defense of Peer Review

Codon

However, I think caution is warranted when drawing sweeping conclusions from these studies because they were each conducted over only a decade (between 1998 and 2008) in just two medical journals (the British Medical Journal and The Annals of Emergency Medicine.) These numbers are quite low and do not inspire confidence.

Science 96
article thumbnail

FDA Approves Roche’s ENSPRYNG for Neuromyelitis Optica Spectrum Disorder (NMOSD)

The Pharma Data

Approval supported by one of the largest clinical trial programmes undertaken for this rare disease. We thank the NMOSD community, including patients and investigators who participated in ENSPRYNG clinical trials.”. Chief Medical Officer and Head of Global Product Development. “We

article thumbnail

FDA for approval to treat VTE and to prevent VTE in children

The Pharma Data

The filing of this application in the US is an important step in helping to address the burden of venous thromboembolism and provide doctors with body weight-based dosing options in pediatric patients,” said Dr Christian Rommel, Head of Research and Development and Member of the Executive Committee at Bayer Pharmaceuticals. “The EINSTEIN-Jr.

FDA 52